Collaborating with Renowned Infectious Disease Specialist Prof. Zhang Wenhong’s Team to Drive the Application of Domestic AI Computing Power in Healthcare

HONG KONG SAR – Media OutReach Newswire – 23 September 2026 – Suanova Technology Limited ("Suanova"), a wholly-owned subsidiary of Yeebo (International Holdings) Limited ("Yeebo"; Stock Code: 00259.HK), recently participated in the inauguration ceremony of the "Suanova Hong Kong-Shanghai Joint Laboratory for AI in Healthcare" held in Shanghai. As a key supporter of the Joint Laboratory, Suanova will provide computing infrastructure, together with full-stack support services including data cleansing, underlying network deployment, and storage system construction, with the aim of advancing the deep integration of domestic computing power and the healthcare industry. The Joint Laboratory is jointly established by Fudan University and The Hong Kong Polytechnic University, with a focus on strategic interdisciplinary AI research in the medical and healthcare sector. It is dedicated to promoting the application of AI technologies in medicine, clinical practice and public health. Prof. Zhou Lei, Vice President of Fudan University, and Prof. Wing-tak Wong, Deputy President and Provost of The Hong Kong Polytechnic University together unveiled the Joint Laboratory. Prof. Yang Hongxia, Executive Director of PolyU Academy for Artificial Intelligence (PAAI), and Prof. Zhang Wenhong, Head of the Institute of Infection and Health of Fudan University, signed the cooperation agreement on behalf of the two institutions. Mr. Douglas Fang, Chairman of Yeebo, and Ms. Li Liu, President of Fudan University Education Development Foundation, signed a donation agreement for the development of the Joint Laboratory. Mr. Daliang Chen, Chief Executive Officer of Suanova, attended the ceremony and delivered a speech. Leading Experts at the Helm, Bridging World-Class Medical Research with Advanced AI The convergence of AI and healthcare has emerged as one of the most important frontiers of global technological innovation. Shanghai is accelerating its development into a globally influential science and technology innovation hub, while Hong Kong is advancing its vision of becoming an international innovation and technology centre. The Joint Laboratory is strategically positioned at the intersection of two key national development regions: the Yangtze River Delta and the Greater Bay Area. Fudan University possesses deep expertise in the fields of infectious diseases, clinical medicine and public health. Leveraging premier institutions such as the National Medical Center for Infectious Diseases and Huashan Hospital, the university provides abundant clinical scenarios and research resources for studies involving the surveillance and early warning of emerging and unexpected infectious diseases, AI-assisted diagnosis of complex infections, and the early identification of antimicrobial resistance risks. The Hong Kong Polytechnic University, through its PAAI Research Institute and Research Institute for Generative AI, possesses strong capabilities in frontier fields including generative AI and domain-specific large language models. Going forward, the two institutions will collaborate on research initiatives spanning generative AI, infectious disease studies, medical informatics, and bioinformatics, while also promoting the translation of research outcomes into real-world applications and industry adoption. Prof. Zhang Wenhong, Head of the Institute of Infection and Health of Fudan University is one of the Joint Laboratory's academic leaders. Widely recognized as one of China's most influential experts in infectious diseases and public health, Professor Zhang has dedicated his career to the diagnosis and treatment of infectious diseases, the prevention and control of major epidemics, and the advancement of public health systems. He earns a strong reputation both within China and internationally. His team has long been engaged in infectious disease prevention and control, translational clinical medicine, and the advancement of public health systems, achieving a series of significant breakthroughs in disease control and public health studies. Prof. Zhang's participation in the establishment of the Joint Laboratory underscores the project's academic excellence and its potential impact on both medical research and clinical practice. Focusing on the Frontier of AI-Driven Healthcare, Empowering Medical Innovation with Domestic Computing Power The Joint Laboratory will focus on exploring a decentralized and domain-specific large model development pathway, enabling hospitals, research institutions, and eventually even individual households to deploy and own their own large AI models. By allowing users to harness the benefits of AI while safeguarding data privacy and sovereignty, this vision closely aligns with Suanova's mission of "enabling every organization to build its own...